Pacific Biosciences Of California (PACB) Other Working Capital Changes (2022 - 2026)

Pacific Biosciences Of California has reported Other Working Capital Changes for 17 years, with the latest figure at $606000.0 in Q2 2026.

• On a quarterly basis, Other Working Capital Changes rose 117.91% year-over-year to $606000.0 in Q2 2026; TTM through Jun 2026 was $1.2 million, a 108.5% increase from a year earlier, with the FY2025 full-year figure at -$8.5 million, up 28.57% from the prior year.
• Other Working Capital Changes was $606000.0 for Q2 2026 at Pacific Biosciences Of California, down from $2.3 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $1.9 million in Q1 2022, with the low at -$5.6 million in Q4 2023.
• Average Other Working Capital Changes over 5 years is -$921333.3, with a median of -$483000.0 recorded in 2025.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes soared 1681.92% in 2022, then plunged 474.71% in 2024.
• Over 5 years, Other Working Capital Changes stood at $18.2 million in 2022, then plunged by 90.69% to $1.7 million in 2023, then slumped by 257.22% to -$2.7 million in 2024, then surged by 73.13% to -$717000.0 in 2025, then soared by 184.52% to $606000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $606000.0 (Q2 2026), $2.3 million (Q1 2026), and -$717000.0 (Q4 2025), per Business Quant data.